Appeal No. 93-3623 Page 6
Application 07/629,690
9. Specifically, the examiner rejected:
Claims in view of Combination
1-3, 6-8, and 21-25 Hrdina and Winter, Leaback, or
Hara
4 and 5 Winter, Hrdina, Johnson,
Leaback, Hara, and Hood
9, 10, and 12-15 Winter, Leaback, Hara, and
Hood
11 Winter, Leaback, Hara, Hood,
and Aebersold
19 and 20 Winter, Hrdina, and Hara
1-8 and 21-25 Urdea, admitted prior art, and
Winter, Hrdina, Leaback, or
Hara
10. The examiner has apparently withdrawn her rejection
under 35 U.S.C. § 112 (Paper 16 at 2) in light of an after-final
amendment (Paper 19 at 1). (Cf. Paper 21 (Ex. Ans.) at 2-3.)
11. Appellant argues the claims in the following groups:
I - 1-3, 6-8, 21-25 (first embodiment); II - 4 and 5 (dependent
from the first embodiment); III - 9-15 (second embodiment); and
IV - 19 and 20 (third embodiment). (Paper 18 at 6.)
FINDINGS OF FACT
A. Protein sequencing
1. Claim 1 requires
A continuous flow reactor including a first tube for passing
reactive fluids and solvents from a peptide sequenator into a
reaction chamber . . . and a second tube for removal of solvents
and reaction products from the reaction chamber which comprises:
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007